A treatment option for the management of patients with intermediate or poor-risk, previously untreated advanced renal cell carcinoma and melanoma with lymph node involvement or metastatic disease who have undergone complete resection, in the adjuvant setting
The form is no longer accepting responses.
Try contacting the owner of the form if you think this is a mistake.
Try contacting the owner of the form if you think this is a mistake.
